Investing in Abbott Laboratories (ABT)

Valuation methodValue, $Upside, %
Artificial intelligence (AI)44.69-58
Intrinsic value (DCF)35.93-66
Graham-Dodd Method31.57-70
Graham Formula0.00-100

Company description

Abbott Laboratories (ABT) is a multinational healthcare company headquartered in Illinois. It was founded in 1888 and has been a leader in the healthcare industry ever since. Today, ABT is a Fortune 500 company and its products are sold in over 160 countries. The company operates in four main segments: established pharmaceuticals, diagnostics, nutrition, and medical devices. ABT's pharmaceutical division is primarily focused on developing and marketing drugs for various therapeutic areas, including immunology, oncology, and neuroscience. The diagnostics segment provides a wide range of products and services for the diagnosis and monitoring of various medical conditions. The nutrition division offers a variety of products for infants, children, and adults, specifically targeting nutritional needs. ABT's medical device segment produces a diverse range of products, including cardiovascular and electrophysiology devices, diabetes care products, and vision care solutions. The company is committed to improving the quality of life for individuals through its innovative and advanced healthcare products. ABT has a strong global presence and is known for its dedication to research and development, with a significant portion of its revenue being reinvested into new product development. Furthermore, the company has a strong commitment to sustainability and corporate responsibility, striving to make a positive impact on both the environment and communities around the world. With a long history of excellence and a focus on innovation, ABT is poised to continue its success and make a significant impact in the healthcare industry.